动物模型的治疗测试一直是转化医学的基石。然而,这种趋势开始发生变化,有利于非动物替代品。考虑到从动物模型到人类应用的正向翻译的失败率很高,上述范式转变绝对是受欢迎的。但对这一进展的热情不应成为完全取代动物试验的基础,因为非动物替代品的可靠性和代表性仍需要更多研究。这尤其适用于免疫系统的分析和免疫疗法的验证。在这篇社论中,我们讨论了反向翻译的应用,作为将人类免疫数据与动物测试强有力地联系起来的可能关键,以提高将免疫疗法转化为前瞻性临床试验的效益风险比。
"点击查看英文标题和摘要"
Reverse translation: the key to increasing the clinical success of immunotherapy?
Therapeutic testing in animal models has been the cornerstone of translational medicine. However, this trend is starting to change in favour of non-animal alternatives. Considering the high failure rates of forward translation from animal models to human application, the above paradigm shift is definitely welcome. But the enthusiasm toward this progress should not become the basis for completely replacing animal testing because the reliability and representativeness of non-animal alternatives still needs more investigation. And this particularly applies to analyses of the immune system and validation of immunotherapies. In this editorial, we discuss the application of reverse translation as a possible key to robustly connecting human immune data with animal testing to increase the benefit-to-risk ratio of translating immunotherapies toward prospective clinical trials.